AKT2 and non-small cell lung carcinoma: According to Chen et al. [16], hyperphosphorylation of ribosomal protein S6 (rpS6) probably regulated by the AKT2/mTOR/p70-S6K1 pathway, signals unfavorable clinical survival in non-small cell lung cancer, especially in the early staged cases [16].